- Home
- KROS vs XNET Comparison
KROS vs XNET Comparison
Compare KROS & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- XNET
- Stock Information
- Founded
- KROS 2015
- XNET 2003
- Country
- KROS United States
- XNET China
- Employees
- KROS N/A
- XNET N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- XNET Computer Software: Prepackaged Software
- Sector
- KROS Health Care
- XNET Technology
- Exchange
- KROS Nasdaq
- XNET Nasdaq
- Market Cap
- KROS 565.0M
- XNET 457.9M
- IPO Year
- KROS 2020
- XNET 2014
- Fundamental
- Price
- KROS $15.66
- XNET $7.55
- Analyst Decision
- KROS Buy
- XNET
- Analyst Count
- KROS 14
- XNET 0
- Target Price
- KROS $20.56
- XNET N/A
- AVG Volume (30 Days)
- KROS 430.7K
- XNET 1.9M
- Earning Date
- KROS 11-05-2025
- XNET 11-13-2025
- Dividend Yield
- KROS N/A
- XNET N/A
- EPS Growth
- KROS N/A
- XNET 5056.12
- EPS
- KROS 0.47
- XNET 11.50
- Revenue
- KROS $232,844,000.00
- XNET $355,826,000.00
- Revenue This Year
- KROS $5,579.44
- XNET N/A
- Revenue Next Year
- KROS N/A
- XNET N/A
- P/E Ratio
- KROS $33.65
- XNET $0.66
- Revenue Growth
- KROS 85820.30
- XNET 11.15
- 52 Week Low
- KROS $9.12
- XNET $1.51
- 52 Week High
- KROS $72.37
- XNET $8.80
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- XNET 61.28
- Support Level
- KROS $15.23
- XNET $7.05
- Resistance Level
- KROS $15.85
- XNET $7.68
- Average True Range (ATR)
- KROS 0.52
- XNET 0.45
- MACD
- KROS 0.01
- XNET -0.05
- Stochastic Oscillator
- KROS 72.91
- XNET 78.29
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.